A Study of Infliximab in the Treatment of Chinese Children With Crohn's Disease
Clinical trial NCT04312659 · COMPLETED
Trial details
- NCT number
- NCT04312659
- Sponsor
- Johnson & Johnson (China) Investment Ltd.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-07-15
- Primary completion
- 2023-09-12
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.